Chronic Urticaria Therapeutics - Epidemiology Forecast to 2023; New Report Launched
Chronic Urticaria Therapeutics - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Chronic Urticaria Therapeutics in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Chronic Urticaria Therapeutics prevalent or incident cases segmented by age, sex and subpopulations.
View full press release